INS and metabolic dysfunction-associated steatotic liver disease: Patients with NAFLD almost universally exhibit systemic insulin and hepatic insulin resistance in addition to adipose tissue and muscle insulin resistance, which are all contributing to the clinical phenotype in diabetes mellitus.